Where Can Farmers Expect the Next Level-Up Technology in Biologicals

The Packer discusses the future of crop biologicals and their potential for significant growth, as discussed by Pam Marrone, co-founder of Invasive Species Corp., during a webinar hosted by the Science Societies. With a long-standing presence in agriculture, biologicals are now gaining renewed attention due to factors like improved return on investment, soil health benefits, reduced carbon emissions, and lower development costs. Market projections suggest global biologicals sales could hit $19.6 billion by 2027, and even match synthetic crop protection sales by 2043.

Marrone highlights the importance of integrating biologicals with conventional chemistry for optimal performance, noting that over 70% of biologicals are used by traditional growers. She categorizes the biologicals market into biopesticides, biostimulants, and biofertilizers, and identifies promising innovations in peptides, proteins, pheromones, and RNA interference. While bioherbicides remain a challenge due to competition with cheap, broad-spectrum options, Marrone sees potential in their future development. She also stresses the importance of studying how biologicals influence soil health and crop microbiomes to support regenerative farming.

Next
Next

Latest Marrone biologics company goes after invasive golden mussel infestation